These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15856755)

  • 1. [Etiology and pathogeneses of Guillain-Barré syndrome and related diseases: focusing on anti-gangliosides antibody].
    Uchibori A; Chiba A
    No To Shinkei; 2005 Feb; 57(2):97-106. PubMed ID: 15856755
    [No Abstract]   [Full Text] [Related]  

  • 2. The Guillain-Barré syndrome: a true case of molecular mimicry.
    Ang CW; Jacobs BC; Laman JD
    Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.
    Simpson BS; Rajabally YA
    Eur J Neurol; 2009 Apr; 16(4):e81. PubMed ID: 19222546
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody].
    Inoue K; Kohriyama T; Ikeda J; Maruyama H; Nakamura S
    Rinsho Shinkeigaku; 2002 Jan; 42(1):13-7. PubMed ID: 12355845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes.
    Willison HJ
    Nat Clin Pract Neurol; 2005 Nov; 1(1):2-3. PubMed ID: 16932482
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
    Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
    Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barré syndrome: immunopathology, update].
    Chiba A
    Nihon Rinsho; 2008 Jun; 66(6):1184-9. PubMed ID: 18540368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Axonal Guillain-Barré syndrome and physiological role of gangliosides in saltatory conduction of myelinated nerve fibers].
    Susuki K; Yuki N
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2479-84. PubMed ID: 15553005
    [No Abstract]   [Full Text] [Related]  

  • 13. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination.
    Yuki N; Takahashi Y; Ihara T; Ito S; Nakajima T; Funakoshi K; Furukawa K; Kobayashi K; Odaka M
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):116-7. PubMed ID: 21084265
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome.
    Lo YL
    Lancet Neurol; 2008 Dec; 7(12):1082-3; author reply 1083-5. PubMed ID: 19007732
    [No Abstract]   [Full Text] [Related]  

  • 19. Gangliosides as targets for autoimmune injury to the nervous system.
    Willison HJ
    J Neurochem; 2007 Nov; 103 Suppl 1():143-9. PubMed ID: 17986149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a rabbit model of neuropathy induced by immunization with gangliosides.
    Moyano AL; Comín R; Lardone RD; Alaniz ME; Theaux R; Irazoqui FJ; Nores GA
    J Neurol Sci; 2008 Sep; 272(1-2):110-4. PubMed ID: 18573503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.